This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Normal tissue architecture determines the evolutionary course of cancer
Nature Communications Open Access 06 April 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McDonald, T. O., Chakrabarti, S. & Michor, F. Nat. Genet. https://doi.org/10.1038/s41588-018-0217-6 (2018).
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).
Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).
Ding, L. et al. Nature 481, 506–510 (2012).
Donnelly, P. & Tavaré, S. Annu. Rev. Genet. 29, 401–421 (1995).
Griffiths, R. C. & Tavaré, S. Stoch. Models 14, 273–295 (1998).
Durrett, R. Ann. Appl. Probab. 23, 230–250 (2013).
Donnelly, P. & Tavaré, S. Annu. Rev. Genet. 29, 401–421 (1995).
Beerenwinkel, N. et al. PLoS Comput. Biol. 3, e225 (2007).
Bozic, I. et al. Proc. Natl. Acad. Sci. USA 107, 18545–18550 (2010).
Kessler, D. A. & Levine, H. Proc. Natl. Acad. Sci. USA 110, 11682–11687 (2013).
Kessler, D. A. & Levine, H. J. Stat. Phys. 158, 783–805 (2015).
Wu, C.-I., Wang, H.-Y., Ling, S. & Lu, X. Annu. Rev. Genet. 50, 347–369 (2016).
Niida, A., Iwasaki, W. M., Innan, H. & Kumar, S. Mol. Biol. Evol. 76, 5605 (2018).
Cannataro, V. L. & Townsend, J. P. Mol. Biol. Evol. 47, 1402 (2018).
Sun, R. et al. Nat. Genet. 49, 1015–1024 (2017).
Williams, M. J. et al. Nat. Genet. 50, 895–903 (2018).
Vogelstein, B. et al. Science 339, 1546–1558 (2013).
Stratton, M. R., Campbell, P. J. & Futreal, P. A. Nature 458, 719–724 (2009).
Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).
Griffith, M. et al. Cell Syst. 1, 210–223 (2015).
Orr, H. A. Nat. Rev. Genet. 10, 531–539 (2009).
Lipinski, K. A. et al. Trends Cancer 2, 49–63 (2016).
Gao, R. et al. Nat. Genet. 48, 1119–1130 (2016).
Acknowledgements
A.S. is supported by the Chris Rokos Fellowship in Evolution and Cancer and by Cancer Research UK (A22909). T.A.G. is supported by Cancer Research UK (A19771). C.P.B. is supported by the Wellcome Trust (097319/Z/11/Z). B.W. is supported by the Geoffrey W. Lewis Post-Doctoral Training fellowship. A.S. and T.A.G. are jointly supported by the Wellcome Trust (202778/B/16/Z and 202778/Z/16/Z, respectively). This work was also supported by Wellcome Trust funding to the Centre for Evolution and Cancer (105104/Z/14/Z).
Author information
Authors and Affiliations
Contributions
B.W. performed mathematical analysis. M.J.W. performed simulation analysis. All authors participated in the discussion, conceived and designed the response, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Werner, B., Williams, M.J., Barnes, C.P. et al. Reply to ‘Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution’. Nat Genet 50, 1624–1626 (2018). https://doi.org/10.1038/s41588-018-0235-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0235-4
This article is cited by
-
Neutral Theory is a tool that should be wielded with care
Nature Human Behaviour (2021)
-
Normal tissue architecture determines the evolutionary course of cancer
Nature Communications (2021)
-
Neutral syndrome
Nature Human Behaviour (2020)